The 2 Minute Medicine® Podcast

In this episode, we explore how social media and celebrity influence are reshaping health behaviors at scale. The article of the week comes from the New England Journal of Medicine and is entitled “Asundexian for secondary stroke prevention.”We start with the viral “Fibermaxxing” trend and its growing focus on microbiome health and satiety. We then examine how Jennifer Aniston’s longevity campaign has pushed red light therapy into the mainstream wellness conversation. Next, we break down an urgent safety warning from the American Lung Association regarding the risks of the mouth taping sleep trend. We conclude with a major global initiative from the World Health Organization aimed at closing the longstanding mortality gap in schizophrenia through integrated care models.

In this episode of the 2 Minute Medicine® Podcast, we explore major advances in precision medicine, beginning with the Phase 3 TALAPRO-3 trial demonstrating improved outcomes with talazoparib combined with enzalutamide in metastatic prostate cancer. We review new evidence from the COBRRA trial comparing apixaban and rivaroxaban, highlighting a significantly improved bleeding profile without loss of efficacy. The episode then examines Eli Lilly’s investigational triple-agonist retatrutide, which is showing unprecedented weight loss and glycemic control in patients with type 2 diabetes. Finally, we discuss a recent FDA warning issued to Novo Nordisk regarding delayed adverse event reporting and what this means for clinicians as GLP-1 therapies continue to expand rapidly in clinical practice.

In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the rapid transformation of artificial intelligence across the healthcare landscape, beginning with Roche’s launch of a large-scale AI factory designed to accelerate drug discovery and manufacturing. We review how NVIDIA-powered systems and “Lab-in-the-Loop” models are enabling real-time refinement of biological predictions and reshaping pharmaceutical research pipelines. The episode then examines Amazon’s expansion of its Health AI assistant, highlighting how conversational AI is changing patient engagement and clinical workflows. We also discuss emerging advances in surgical robotics, including NVIDIA’s Isaac GR00T N model, which may enhance procedural precision and standardize outcomes. Finally, we address growing ethical concerns surrounding AI-powered mental health chatbots, including risks related to bias, safety, and inadequate escalation in high-risk scenarios.

In this episode of the 2 Minute Medicine® Podcast, we explore a major public health moment as White House Chief of Staff Susie Wiles’ breast cancer diagnosis drives a national surge in screening awareness and reinforces the importance of early detection. We review new data on firearm acquisition trends following the COVID-19 pandemic, highlighting shifting demographics and implications for public health monitoring. The episode then examines how Jensen Huang’s NVIDIA GTC 2026 keynote transformed healthcare artificial intelligence into a pop-culture phenomenon and signaled a shift toward AI as essential clinical infrastructure. We also break down the landmark American College of Sports Medicine guidelines that simplify resistance training recommendations for longevity and functional health. Finally, we discuss a critical consumer safety warning surrounding high-pressure cosmetic surgery chains and the urgent call for tighter oversight and patient protection.

In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the remarkable evolution of GLP-1 receptor agonists from injectable diabetes therapies to some of the most influential drugs in modern medicine. We review the landmark clinical trials behind semaglutide and tirzepatide that transformed expectations for medical weight loss. The episode then examines the emerging race toward oral GLP-1 medications, including Novo Nordisk’s high-dose oral semaglutide and Eli Lilly’s small-molecule orforglipron. Finally, we look ahead to the next generation of metabolic therapies that may soon make once-daily pills the standard for obesity and diabetes care.

This Pharma Roundup episode reviews four major regulatory and clinical developments shaping early 2026. It begins with the Food and Drug Administration approval of Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for uncomplicated gonorrhea offering a needle-free alternative amid rising antimicrobial resistance. The episode then covers the approval of Yartemlea for hematopoietic stem cell transplant–associated thrombotic microangiopathy, signaling a shift toward disease-modifying therapy. It also examines the FDA’s new risk-based flexibility in Chemistry, Manufacturing, and Controls requirements for cell and gene therapies. The episode concludes with a discussion of the partial clinical hold on ifinatamab deruxtecan following safety concerns related to interstitial lung disease.

In this episode, we lead with our article of the week from the New England Journal of Medicine examining the noninferiority of a single-dose HPV vaccine compared with the standard two-dose regimen. We then dive into a detailed edition of The Scan, discussing how oral semaglutide is reshaping routine obesity visits and the real-world challenges of daily medication adherence. The conversation turns to the rise of AI deepfake doctors and the growing threat posed by counterfeit injectable medications circulating online. Next, we break down highlights from CES 2026, including new longevity-focused smart scales capable of generating sixty biomarkers in a single scan. We close with an analysis of how television medical dramas misrepresent CPR and why this portrayal may negatively affect bystander response in real-world emergencies.

In this episode of the 2 Minute Medicine Podcast: Pharma Roundup, we explore how innovation, regulation, and global strategy are reshaping the pharmaceutical landscape. We begin with the FDA’s approval of Enbumyst, the first intranasal loop diuretic for edema, offering patients with heart, kidney, or liver disease a faster and more convenient alternative to oral or intravenous therapy. Next, we turn to the FDA’s sweeping crackdown on misleading drug advertisements, marking a dramatic shift after years of lax enforcement and signaling a renewed emphasis on patient safety and transparency. We then spotlight Samsung BioLogics’ $1.3 billion U.S. contract, a deal that underscores how pharmaceutical manufacturing is adapting to tariff pressures and the need for secure biologics supply chains. Finally, we close with new data showing how Wegovy not only promotes weight loss but also reduces “food noise” and enhances mental well-being for patients, reframing obesity as both a metabolic and psychological condition. Together, these stories highlight how drug delivery, regulation, global production, and mental health insights are converging to define the next era of pharmaceutical care.

In this episode of the 2 Minute Medicine Podcast: AI Roundup, we examine how artificial intelligence is rapidly transitioning from research to real-world medical impact. We begin with Eli Lilly’s launch of TuneLab, a billion-dollar federated AI platform that opens the company’s research models to smaller biotech partners, marking a major shift toward collaborative drug discovery. Next, we explore a-Heal, a newly unveiled AI-powered smart bandage that accelerates wound healing by 25 percent in preclinical studies through algorithm-guided microcurrent therapy. From there, we turn to Punjab, India, where the state government has launched the country’s first AI-driven public health screening initiative, using thermal imaging and smart diagnostic tools to detect breast cancer, cervical cancer, and vision loss. Together, these stories capture AI’s evolution from molecule modeling to bedside innovation to population-scale screening. Each reflects how data, devices, and public policy are converging to transform the global landscape of health care.

Welcome to this week’s episode of The 2 Minute Medicine Podcast, where practicing physicians break down the latest in clinical research and health care news.We begin with our Article of the Week, a New England Journal of Medicine study titled “Global Effect of Cardiovascular Risk Factors on Lifetime Estimates,” which analyzes data from more than two million participants across 39 countries. The findings show that individuals without common risk factors such as hypertension and smoking can gain over a decade of heart disease-free life, underscoring the importance of prevention on a global scale.In our Scan segment, we discuss the FDA’s approval of leucovorin calcium for cerebral folate deficiency and the ongoing discussion around acetaminophen use in pregnancy. We then explore the expanding world of wearable health technology, including the Oura Ring’s growing presence in both consumer and professional settings, and the questions it raises about clinical oversight. Next, we review Eli Lilly’s new oral GLP-1 medication, orforglipron, which achieved more than twelve percent weight loss in phase III trials and could make obesity treatment more accessible. Finally, we examine Florida’s evolving vaccine policy and its decision to reconsider certain school immunization requirements amid a national decline in vaccination rates.Each story highlights how innovation, regulation, and public health continue to shape the practice of modern medicine.

In this episode, we lead with our article of the week from the New England Journal of Medicine, “Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.” We then cover the FDA’s authorization of updated, limited-access COVID-19 boosters and ongoing concerns about uptake. Next, we track the seasonal surge in West Nile virus during peak mosquito activity. We also discuss John Cena’s skin cancer story as a timely call for men to adopt better prevention habits. We close with how celebrity recovery narratives, from addiction to anxiety, are reshaping public conversations about mental health.

In this episode of the 2 Minute Medicine Podcast: AI Roundup, we explore how artificial intelligence is reshaping health care at every level. We begin with Illinois’ landmark law banning unsupervised AI in mental health care, the first of its kind in the U.S. We then spotlight Abridge’s $300 million funding round, as its clinical AI scribe continues to scale across more than 150 health systems. Next, we turn to DeepMind’s reflections on the limits of AI in medicine, where algorithms excel in analysis but fall short in compassion. Finally, we close with Bill Gates’ $1 million Alzheimer’s AI Prize, designed to accelerate innovation against a devastating neurodegenerative disease. Together, these stories show how policy, startups, research, and philanthropy are defining the evolving boundaries of AI in health.

In this episode, we start with Doximity’s nationwide launch of a free AI scribe for every U.S. clinician, designed to cut charting time in half and ease burnout, with analysts predicting it could spark a major pricing shake-up in the medical dictation market. Next, we spotlight Ultromics, an Oxford spin-out that just raised $55 million to expand its FDA-cleared cardiac-ultrasound AI, which detects hidden forms of heart failure up to 74% more accurately than manual reads and could transform early diagnosis. Then we head to England, where the NHS’s first AI-run physio clinic slashed back-pain waiting times by nearly half, delivering same-day virtual assessments and freeing hundreds of clinician hours each month. Finally, we explore Everlab, a preventive-care platform pairing full-body scans with large-language-model “health agents” to catch disease years earlier, backed by a $10 million raise and aiming to make longevity-focused care accessible at scale. Together, these stories reveal how AI is trimming paperwork, sharpening diagnostics, shrinking queues, and pushing proactive medicine closer to everyday patients.

In this episode, we begin with discussing our article of the week which comes  from JAMA Network Open and is entitled “Oral vancomycin for prevention of recurrent clostridioides difficile infection: A randomized clinical trial.” Then, we discuss Venus Williams’ triumphant return to tennis and her advocacy for fibroid awareness and insurance reform. Then we turn to Matt McGorry’s long COVID journey and the scientific breakthrough that redefines the condition as biologically diverse. Next, we examine a global crisis of contaminated pediatric medicines and the WHO’s urgent call for regulatory action. Finally, we highlight Tammy Slaton’s 500-pound transformation and the lingering barriers that shape access to bariatric surgery in the United States.

In this episode, we open with Jessie J’s stage-I breast-cancer disclosure and the immediate surge in mammogram bookings that followed across the United Kingdom. Next, we dive into Olympic swimmer Kyle Chalmers’s frank discussion of anxiety and his virtual workshops that now reach hundreds of young athletes. We then explore Real Housewives star Dolores Catania’s atrial-fibrillation ablation and her plea for women to take palpitations seriously. Finally, we examine how a prostate-cancer subplot on And Just Like That spurred a record spike in Google searches for PSA testing and doubled virtual urology consults. Together these stories underscore the persuasive power of public voices and popular media in driving preventive care, mental-health advocacy, and timely cardiovascular and oncologic screenings.

Welcome to this week’s Pharma Roundup. In this episode, we begin with a peri operative immunotherapy that lowers gastric cancer relapse, move to an FDA decision that lets a prostate cancer pill skip chemotherapy prerequisites, continue with a wearable injector that trims myeloma treatment to five minutes, and finish with the agency’s choice to drop extra safety hurdles so more hospitals can deliver lifesaving CAR T therapy. Together these stories underscore faster surgeries, wider oral options, time saving devices, and streamlined regulation that could bring cutting edge care closer to patients everywhere.

In this episode, we kick things off with a deep dive into the UK’s miONCO-Dx trial, an AI-powered blood test that detects 12 common cancers with 99 % accuracy and could one day replace colonoscopies. Backed by £2.4 million in NHS funding and already analyzing its first wave of samples, the study exemplifies Britain’s push for tech-driven early cancer detection. Then in the second half of the episode, we begin with a discussion about Emory Healthcare’s AI-enhanced virtual nursing program and its success in cutting patient falls. Then we take a closer look at Insilico Medicine’s $110 million funding round and how its Pharma.AI platform is shrinking drug-discovery timelines. After that, we examine real-world NHS data showing the Limbic Care chatbot’s impact on therapy attendance and recovery rates. Finally, we discuss Aura, a new AI app that helps parents spot early signs of emotional distress in children by analyzing online behavior.

In this episode, we begin with a discussion about our article of the week. Our article of the week comes from The New England Journal of Medicine and is entitled “Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.” Then in the second half of the episode, we begin with a discussion about Billy Joel’s newly disclosed diagnosis of normal pressure hydrocephalus and what his case teaches us about spotting this reversible dementia mimic sooner. Then we take a closer look at model and advocate Gigi Robinson’s experience with hypermobile Ehlers-Danlos syndrome and how breast-reduction surgery slashed her pain while exposing persistent insurance hurdles. After that, we examine new research linking each 1 °C rise in Middle East and North African temperatures to a sharp surge in women’s cancer incidence and mortality. Finally, we discuss the discovery of West Nile virus fragments in UK mosquitoes and the public-health actions underway as climate change expands vector-borne threats.

In this episode, we kick things off with our article of the week which comes from JAMA Network Open and is entitled “Cannabis Use and Misuse Following Recreational Cannabis Legalization”Then, we take a look at the devastating impact of Cyclone Mocha on health systems in Myanmar and Bangladesh. We explore how natural disasters don’t just damage infrastructure—they also cripple access to care and mental health support. Then we pivot to an exciting tech meets wellness update as Serena Williams launches a new app that blends fitness with mindfulness, aiming to make mental health as mainstream as a gym membership. After that, we dive into a global health curveball as snakebites are on the rise and climate change is slithering behind the scenes. We follow that with a fascinating study out of Stanford showing that elite athletes may have stronger immune responses to vaccines, giving new meaning to peak performance. Finally, we close with a major labor movement in India where healthcare workers are striking to demand better conditions and pay amid rising COVID-19 cases. Each story ties into the big picture of health, equity, and how our systems are or aren’t keeping up.

In this episode, we begin with a discussion about our article of the week.,Our article of the week comes from The Lancet Oncology and is entitled “Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study.” Then in the second half of the episode, we begin with a discussion about a new, three-in-one therapy for endometriosis. Then we take a closer look at a planned Center for Disease Control and Prevention study for connections between vaccines and autism. After that, we examine the effects of extended durations of space flight on human health. Finally, we discuss the relationship between eating well and healthy aging.

In this episode, we begin with a discussion about our article of the week, which comes from the New England Journal of Medicine and is entitled “Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections”. the United States’ measles outbreak. Then in the second half of the episode, we take a closer look at how President Trump’s tariffs may affect healthcare both within the United States and abroad. After that, we examine Pope Francis’ current admission for respiratory illness. Finally, we discuss Utah’s proposal to ban fluoride in water.

In this episode, we discuss our article of the week  from JAMA Network Open which is entitled “Patient complexity, social factors, and hospitalization outcomes at academic and community hospitals.” Then, we discuss the positive relief on pain and anxiety that immersive imagery and hypnotic techniques can provide patients with. Further, we discuss the TikTok ban, the impact of smart devices on our overall health and more!

In this episode, we begin with a discussion about a recent surge in human metapneumovirus cases in China. Then we take a closer look at the United States Surgeon General’s new recommendations on alcohol intake. After that, we examine recent developments in the avian flu outbreak. Finally, we discuss how strenuous exercise can be detrimental to women’s health. We are excited to share that the 2nd edition of our Classics in Medicine book is available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

In the first half of this episode we cover our article of the week which comes from  the New England Journal of Medicine and is entitled “Invasive Treatment Strategy for Older Patients with Myocardial Infarction.“ In the second half, we start with a discussion about Jamie Foxx’s hemorrhagic stroke that led to his 2023 hospitalization. Then we take a closer look at how paracetamol might have a more serious side-effect profile than previously believed. After that, we examine the battle between the FDA and vaping in the Supreme Court. Finally, we discuss the coffee and tea’s protective effects against head and neck cancer.

In this episode, we begin with a discussion about Ozempic’s potential in treating alcohol use disorder. Then we take a closer look at how President-Elect Trump's next term might affect healthcare.. After that, we examine a new therapy for slowing Alzheimer’s disease. Finally, we discuss the resurgence of the avian flu.

In the first half of this episode, we cover our article of the week which comes from the New England Journal of Medicine and is entitled “Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women”. In the second half, we begin with a discussion about a new gene therapy to treat sickle cell disease. Then we take a closer look at how lupus can affect motherhood. After that, we examine the short and long-term effects of hurricanes on health. Finally, we discuss Rafael Nadal’s recent retirement and the consequences of sports injuries.

Description In the first half of this episode, we cover our article of the week which comes from the New England Journal of Medicine and is entitled “Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury”. In the second half, we begin with a discussion about using viruses to kill bacteria. Then we take a closer at reductions in rates of teenage vaping across the US. After that, we examine the recent FDA approval of AirPods as hearing aids. Finally, we discuss Brian May’s recent stroke, and how to identify the signs of strokes.

In this episode we begin by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “The annual cost of cancer screening in the United States.” In the second half, we begin with a discussion about COVID-19, asthma, and exercise. Then we take a closer look at new treatments for life-threatening allergic reactions. After that, we examine the recent FDA rejection of MDMA for patients with PTSD. Finally, we discuss POTS, and how some individuals have overcome their diagnosis to achieve greatness.We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

In this episode we begin by discussing our article of the weekwhich  comes from the New England Journal of Medicine and is entitled “Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation”. In the second half, we begin with a discussion about recent blood tests showing promising responses. Then we take a look at a recent study that investigated a new preventative treatment for HIV. After that, we discuss skin cancer and a recent diagnosis. Finally, we discuss some of the recent aspects affecting the health of athletes at the Olympic Games. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin with a discussion about our article of the week from JAMA network open entitled "Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts". In the second half of the episode, we begin with Kate Middleton's appearance during chemotherapy treatment. Next, we explore the increasing popularity of whole-body MRI scans for early disease detection. Following that, we examine the spread of new COVID-19 strains in the US. Lastly, we discuss the implications of human exposure to microplastics and strategies to minimize this exposure.

In the first half, we review our article of the week which comes from The New England Journal of Medicine and is entitled “A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia”. In the second half of the episode, we begin with a discussion about intestinal transplants and a recent case of a rare intestinal injury. Then we take a closer look at bird flu and how it is affecting humans and animals alike. After that, we discuss the upcoming Olympic games and injuries. Finally, we discuss the latest studies of artificial sweeteners, their risks, and benefits.

In the first half of this episode we cover our article of the week which comes from The Lancet and is entitled “Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials“.  In the second half, we start with covering news including how the ruling that Florida's ban on gender-affirming care was deemed to be unconstitutional. Then we cover Porzingis’s rare tendon injury at the time of the NBA finals. After that, we take a look at the new AI-based model developed to predict Parkinson’s disease years before the onset of motor symptoms. Finally, we go over the implications of increased screen time on children's language development. 

In this episode, we begin by discussing our article of the week which comes from Annals of Internal Medicine and is entitled “Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022." Next, we cover the experiences of Neuralink’s first patient with a brain implant and take a closer look at the increased rates of lung cancer in non-smoking female Asians. Last but not least, we take a look at the new findings regarding the health benefits of the Mediterranean diet and discuss the overall impact of sleep hygiene and a healthy diet on general health and well-being.

We begin with a discussion about the keto diet and discuss the recent studies about the influence of keto on the brain. Then we take a closer look at a recent recommendation around breastfeeding for mothers with HIV. After that, we discuss a new treatment for lung cancer, and the growing field of immunotherapy. Finally, we look at spicy foods, and how an internet challenge led to a catastrophe. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin with a discussion about our article of the week from the BMJ, entitled prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. In the second half, we start off by talking about the risks and benefits of vampire facials. Then we discuss the importance of raising awareness about the fentanyl crisis. After that, we take a look at the implications of marijuana reclassification. Finally, we go over new findings about the safety of hormonal therapy for menopause. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin with a discussion about our article of the week from the Lancet and is entitled “Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data“. In the second half of the episode we have a conversation about the rise in counterfeit Botox use, the cognitive benefits of playing chess, pros and cons of melatonin supplements and the recent increase in reported Measles cases. 

We begin with a discussion about our article of the week from JAMA, entitled “Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes”  In the second half of the episode, we begin with talking about a pioneering immunotherapy approach for brain cancer. Then we discuss the advantages of access to over-the-counter birth control. After that, we take a look at abortion ban rulings issued by the Florida Supreme Court. Finally, we go over cardiac pacemakers and how they have changed over time. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin with a discussion about our article of the week entitled “Electronic nicotine delivery systems for smoking cessation. In the second half of the episode, we discuss Kate Middleton’s recent cancer diagnosis and have a conversation about cancer trends that have recently made the news. Next, we follow with a discussion about the first person to undergo kidney transplantation from a genetically altered pig, take a closer look at the solar eclipse and its impact on eye health, and conclude with a conversation about lab-grown meat and what the research has shown so far.

In this episode, we begin with a discussion about our article of the week entitled “An umbrella review and meta-analysis of meta-analyses of the impact of Ramadan fasting on the metabolic syndrome components“. Next, we talk about a new cure strategy for HIV. Then we discuss issues revolving around psychotropic polypharmacy in youth. After that, we take a look at a new method to improve IVF treatments. Finally, we go over the recent cyberattack at UnitedHealth’s Change Healthcare and its consequences.

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.” Then we discuss the challenges and recovery after having brain aneurysm and talk about the first disease modifying FDA approved drug for Alzheimer’s disease. After that, we take a look at liver transplant in children. Finally, we go over psoriasis and briefly go over risk factors and treatments.

We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Apixaban for stroke prevention in subclinical atrial fibrillation”. In the second half of the episode, we begin with a discussion about stroke in young patients with Lupus. Then we discuss how Starting January 29th British Columbia began providing Canada’s first-at-home self HPV screening test kits for cervical cancer. Last but not least, we take a closer look at acne, current treatments, and a possible vaccine that has shown promise in mouse models, and conclude with a conversation about opioids.

We begin this episode by discussing our article of the week which comes from the BMC Nutrition Journal and is entitled “Clusters of carbohydrate-rich foods and associations with type 2 diabetes incidence: a prospective cohort study.” We begin with a discussion about blood donation, and the decline we are seeing in blood donors. Then we take a closer look at lead poisoning in the context of a recent recall of contaminated cinnamon applesauce products. After that, we investigate multiple sclerosis and how it can affect one’s life. Finally, we discuss the cold winter temperatures, the risks of the cold, and how we can stay safe this winter.

In this episode, we begin by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Teplizumab and beta-cell function in newly diagnosed type 1 diabetes.” Then we take a closer look at allergies and new treatments on the horizon for food allergies. Next, a discussion about lung cancer, following the recent passing of Andre Braugher. Last but not least, we discuss New Year’s resolutions along with evidence-based ways to make them last and explore the rise in cases of counterfeit Ozempic use, and how this has affected the world. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the Annals of Internal Medicine and is entitled “Cardiovascular health of middle-aged US adults by income level, 1999 to March 2020: A serial cross-sectional study.” In the second half, we begin by discussing an increasingly popular procedure used in infants who are struggling with breastfeeding. Then we delve into the new findings that a hormone, GDF15, is linked to morning sickness. After this, we discuss ketamine, the drug that was implicated in the tragic passing of 'Friends' star Matthew Perry. Finally, we end with a conversation about the ongoing generic drug shortages occurring across the country.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Trial of Botulinum Toxin for Isolated or Essential Head Tremor”. In the second half, we discuss how as semaglutide, also known by brand names Ozempic or Wegovy, continues to make headlines, a new drug called Zepbound is entering the weight loss sphere. Next, we discuss organ transplants and a new antibiotics developed for the treament of  gonorrhea, Zoliflodacin. Last but not least, we discuss why ⁠March of Dimes⁠, a maternal and infant health organization, issued ⁠a D+ to the USA⁠ for the 2nd year in a row for its relatively high rate of preterm births.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠⁠https://bit.ly/2zZnJt9⁠

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021”.  We then dive deeper into a discussion about seasonal affective disorder, its treatment, and its impact on the population. Then we take a closer look at the Movember movement and how it relates to men’s health. After that, we discuss the recent surge in syphilis cases and what can be done about it. Last, but not least, we have a conversation about substance use disorders in the wake of Matthew Perry’s passing. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study”. In the second half of our episode, we start off by discussing the issue of performance-enhancing drugs in sports following the news of a  banned substance scandal in the men's marathon. Next, we will dive into the NHL's Pride Tape ban and their decision to reverse the ban following public push-back. Finally, we end with conversations about the bedbug outbreak in Paris, and new studies highlighting the value of wearable technology in diagnosing and monitoring Parkinson's disease. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled ““Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.” In the second half of our episode, we begin by taking a closer look at the public heath crisis in Gaza. Next, we discuss a recently published study in JAMA, and examine the possible link between ADHD and Dementia. Last but not least, a short discussion about the significance of October being National Pregnancy and Infant Loss Awareness Month. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH”. In the second half of our episode, we begin by exploring the recently announced price drop for a popular tuberculosis test. Then we discuss Sufjan Stevens' ongoing battle with the rare autoimmune condition, Guillain-Barre Syndrome. Finally, we end with a conversation about newly developed tests to identify medical abortions and the ongoing American Red Cross blood supply shortage.